| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.naturalcapsules.com | |
| Market Cap | 362.65 Cr. | |
| Enterprise Value(EV) | 430.88 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 22.37 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 17.34 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 32.00 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 115.45 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 3.36 | Calculated using Price: 387.90 |
| Dividend Yield | 0.26 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.93 Cr. | 9,349,050 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form. | ||
| 1 Day |
|
-0.96% |
| 1 Week |
|
-10.27% |
| 1 Month |
|
-1.51% |
| 3 Month |
|
-25.60% |
| 6 Month |
|
-30.74% |
| 1 Year |
|
-15.51% |
| 2 Year |
|
+342.30% |
| 5 Year |
|
+357.05% |
| 10 Year |
|
+1351.18% |
| 5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 2.05 | 3.50 | 1.54 | 11.74 | 19.18 | |
| Return on Capital Employed (%) | 3.71 | 4.51 | 3.71 | 14.52 | 20.92 | |
| Return on Assets (%) | 1.56 | 2.66 | 1.16 | 8.05 | 10.65 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 54 | 55 | 56 | 62 | 83 | 101 | |
| Non Curr. Liab. | 2 | 1 | 1 | 2 | 35 | 58 | |
| Curr. Liab. | 15 | 16 | 18 | 33 | 46 | 63 | |
| Minority Int. | |||||||
| Equity & Liab. | 71 | 73 | 75 | 97 | 164 | 223 | |
| Non Curr. Assets | 29 | 35 | 37 | 47 | 89 | 121 | |
| Curr. Assets | 42 | 38 | 38 | 50 | 76 | 102 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 71 | 73 | 75 | 97 | 164 | 223 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 55 | 60 | 62 | 80 | 135 | 176 | |
| Other Income | 1 | 1 | 1 | 1 | 2 | 1 | |
| Total Income | 56 | 61 | 63 | 80 | 137 | 177 | |
| Total Expenditure | -49 | -55 | -56 | -68 | -111 | -140 | |
| PBIDT | 6 | 6 | 6 | 12 | 27 | 38 | |
| Interest | 0 | -1 | -1 | -1 | -2 | -3 | |
| Depreciation | -4 | -3 | -4 | -4 | -5 | -7 | |
| Taxation | -1 | 0 | -1 | -2 | -5 | -7 | |
| Exceptional Items | 0 | 2 | |||||
| PAT | 1 | 2 | 1 | 7 | 14 | 21 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | 0 | 0 | |||||
| Consolidated Net Profit | 1 | 2 | 1 | 7 | 14 | 21 | |
| Adjusted EPS | 1 | 3 | 1 | 9 | 20 | 27 |
| Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 5 | 2 | 7 | 6 | 1 | |
| Cash Fr. Inv. | -1 | -7 | -6 | -9 | -46 | |
| Cash Fr. Finan. | -4 | 4 | -1 | 3 | 46 | |
| Net Change | 0 | -1 | 0 | 0 | 1 | |
| Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 1 |
|
Tue, 21 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that a shareholder has reported to company about loss of his share certificate and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached herewith. |
|
Tue, 07 Mar 2023
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We wish to inform you that M/S Polson Tie-up Private Limited have invested Rs. 6 26 62 500/- (Rupees Six Crore Twenty Six Lakhs Sixty Thousand Five Hundred Only) in Subsidiary Company M/S Natural Biogenex Private Limited at a pre money valuation of Rs. 243.75 Cr.The Board of M/S Natural Biogenex Private Limited (Subsidiary) on their meeting held today i.e. 07.03.2023 have considered and approved Allotment of 5 57 000 equity shares of Rs. 10/- each at Rs. 112.50 per shares to M/S Polson Tie-up Private Limited. |
|
Tue, 28 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that a shareholder has reported to company about loss of his share certificate and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached. |
| Tue, 28 Mar 2023 |
High Delivery Percentage
|
Making Lower Lows for 3 days
|
Close Within 52 Week Low Zone
|
High Decrease in 3 Months
|
High Decrease in 6 Months
|
Equities
M.F.
Sectors